We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dynamic Splinting for Excessive Pronation Following CVA (SupPro Botox)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00900692
Recruitment Status : Withdrawn
First Posted : May 13, 2009
Last Update Posted : July 11, 2013
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of this study is to examine range of motion and lasting effects of Botox injections along with the use of the Supination Dynasplint.

Condition or disease Intervention/treatment
Pronation Contracture Device: Dynasplint

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Dynamic Splinting for Excessive Pronation Following CVA: A Randomized, Controlled Tial
Study Start Date : May 2009
Estimated Primary Completion Date : September 2016
Estimated Study Completion Date : October 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Botox
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: Dynasplint Group
Along with the standard of care Botox and manual therapy, patients will use the Supination Dynasplint every day
Device: Dynasplint
Dynamic splinting utilizes the protocols of Low-Load Prolonged Stretch (LLPS) with calibrated adjustable tension to increase Total End Range Time (TERT)to reduce contracture. The Dynasplint or "Experimental" group will add this therapy to their standard of care regimen
No Intervention: Standard of care
Patients in the standard of care group will have the standard Botox treatments and manual therapy with no additional interventions.


Outcome Measures

Primary Outcome Measures :
  1. ROM changes with use of treatment [ Time Frame: 20 weeks ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria

Patients enrolled will have been diagnosed with excessive pronation following a stroke and will display the following symptoms:

  • Pronation Contracture
  • Ability to provide consent and follow directions as related to the protocol

Exclusion Criteria

  • Treatment with Benzodiazepines
  • Treatment with Baclofen (pump or oral)
  • Treatment with Dantrolene sodium
  • Treatment with Tizanidine
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00900692


Locations
United States, Indiana
Rehabilitation Associates of Indiana
Indianapolis, Indiana, United States, 46250
Sponsors and Collaborators
Dynasplint Systems, Inc.
Investigators
Principal Investigator: Marc E Duerden, MD Rehabilitation Associates of Indiana
More Information

Publications:
Cooper. Et al. Proceedings of the Stroke Disparities Advisory Panel Meeting, Nov 08, 2002, Bethesda MD, National Institute of Neurological Disorders and Stroke
Lai JM, Francisco GE, Willis FB. Dynamic Splinting on Range of Motion and Spasticity after Treatment with Botulinum Toxin-A: a Randomized, Controlled Pilot Study. Advances in Therapy. (March 2009, E-Pub February)

Responsible Party: Dynasplint Systems, Inc.
ClinicalTrials.gov Identifier: NCT00900692     History of Changes
Other Study ID Numbers: 2009.001
First Posted: May 13, 2009    Key Record Dates
Last Update Posted: July 11, 2013
Last Verified: July 2013

Keywords provided by Dynasplint Systems, Inc.:
Excessive pronation
CVA
Forearm
Excessive pronation following CVA

Additional relevant MeSH terms:
Contracture
Joint Diseases
Musculoskeletal Diseases
Muscular Diseases